Home / Recalls / Padagis US LLC / D-0139-2024

D-0139-2024 Class II Ongoing

Recalled by Padagis US LLC — Minneapolis, MN

Recall Details

Product Type
Drugs
Report Date
December 13, 2023
Initiation Date
November 1, 2023
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,032 bottles

Product Description

Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30

Reason for Recall

Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules

Distribution Pattern

Nationwide in the USA

Code Information

Lot: 231104, 231105, 231106, exp 7/31/2025

Other recalls by Padagis US LLC

  • D-0246-2025 Class II — Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use (February 6, 2025)
  • D-0048-2025 Class III — Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only, Manufa (October 11, 2024)
  • D-0081-2024 Class II — Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-f (September 28, 2023)
  • D-0464-2023 Class III — Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl o (February 21, 2023)
  • D-1497-2022 Class II — Triamcinolone Acetonide Cream USP, 0.1%, 80 g tube, Rx Only, Manufactured By Per (August 17, 2022)
  • D-0372-2022 Class II — Nitroglycerin Lingual Spray, 400 mcg per spray, 200 metered sprays, 12 g bottles (December 27, 2021)